Active Clinical Trials

Pemetrexed Disodium/Observation in Treating Patients W/ Malignant Pleural Mesothelioma w/Out Progressive Disease After 1st Line Chemotherapy

By April 24, 2017No Comments


Malignant Mesothelioma

Estimated Enrollment: 68

Age Group: 18 Years and older   (Adult, Senior)

Gender: All

Study Type: Interventional

Study Design Allocation: Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: No masking|Primary Purpose: Treatment

Study ID Numbers: CALGB-30901|U10CA180821|U10CA031946|CDR0000667496

Study First Received: March 11, 2010

Last Updated: March 6, 2017

Estimated Primary Completion Date: July 2017


Primary Outcome Measures:

Progression-free survival|Overall survival|Frequency of responses|Toxicity

Sponsors and Collaborators:

Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI)

Website Link:

Leave a Reply

Call Now ButtonCall Now